Joshua E. Freeman

Array ( [id] => 5586036 [patent_doc_number] => 20090105238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Compounds and Relative use for the Control of Phytopathogens' [patent_app_type] => utility [patent_app_number] => 12/083393 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6654 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105238.pdf [firstpage_image] =>[orig_patent_app_number] => 12083393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688604 [patent_doc_number] => 20070106094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Process For Preparing 4-Pentafluorosulfanylbenzoylguanidines' [patent_app_type] => utility [patent_app_number] => 11/539237 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7114 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20070106094.pdf [firstpage_image] =>[orig_patent_app_number] => 11539237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5237192 [patent_doc_number] => 20070129349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/539219 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17161 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129349.pdf [firstpage_image] =>[orig_patent_app_number] => 11539219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 394123 [patent_doc_number] => 07297818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-20 [patent_title] => 'Adamantane derivatives' [patent_app_type] => utility [patent_app_number] => 11/529746 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19044 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/297/07297818.pdf [firstpage_image] =>[orig_patent_app_number] => 11529746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 591301 [patent_doc_number] => 07435851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Puleganic amides' [patent_app_type] => utility [patent_app_number] => 11/541057 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6936 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435851.pdf [firstpage_image] =>[orig_patent_app_number] => 11541057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5091601 [patent_doc_number] => 20070231240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'METHOD FOR PREPARING HYDROXYLAMINE' [patent_app_type] => utility [patent_app_number] => 11/534167 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2727 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231240.pdf [firstpage_image] =>[orig_patent_app_number] => 11534167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035420 [patent_doc_number] => 20070099959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'O-Aminophenol derivatives and colorants containing these compounds' [patent_app_type] => utility [patent_app_number] => 11/524149 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8200 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099959.pdf [firstpage_image] =>[orig_patent_app_number] => 11524149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 439841 [patent_doc_number] => 07259271 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-21 [patent_title] => 'Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation' [patent_app_type] => utility [patent_app_number] => 11/533462 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6395 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259271.pdf [firstpage_image] =>[orig_patent_app_number] => 11533462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995160 [patent_doc_number] => 20070010505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Methods of treating disease states using antiangiogenic agents' [patent_app_type] => utility [patent_app_number] => 11/519570 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17558 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010505.pdf [firstpage_image] =>[orig_patent_app_number] => 11519570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705135 [patent_doc_number] => 20080064659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'EPOXYKETONE-BASED IMMUNOPROTEASOME INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/531129 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7030 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064659.pdf [firstpage_image] =>[orig_patent_app_number] => 11531129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142674 [patent_doc_number] => 20070004890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof' [patent_app_type] => utility [patent_app_number] => 11/519631 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8300 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004890.pdf [firstpage_image] =>[orig_patent_app_number] => 11519631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586057 [patent_doc_number] => 20090105259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Acyclic 1,4-Diamines and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/065772 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41557 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105259.pdf [firstpage_image] =>[orig_patent_app_number] => 12065772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292506 [patent_doc_number] => 07544799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use' [patent_app_type] => utility [patent_app_number] => 11/515997 [patent_app_country] => US [patent_app_date] => 2006-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7375 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544799.pdf [firstpage_image] =>[orig_patent_app_number] => 11515997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183726 [patent_doc_number] => 20070055080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Process for preparing ester oxazolidine compounds and their conversion to Florfenicol' [patent_app_type] => utility [patent_app_number] => 11/515135 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8163 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20070055080.pdf [firstpage_image] =>[orig_patent_app_number] => 11515135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494728 [patent_doc_number] => 07211667 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states' [patent_app_type] => utility [patent_app_number] => 11/512024 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7480 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211667.pdf [firstpage_image] =>[orig_patent_app_number] => 11512024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149527 [patent_doc_number] => 20070049587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Factor Xa inhibitors' [patent_app_type] => utility [patent_app_number] => 11/510831 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13243 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049587.pdf [firstpage_image] =>[orig_patent_app_number] => 11510831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853322 [patent_doc_number] => 20080319065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Systemic and Intrathecal Effects of a Novel Series of Phospholipase A2 Inhibitors on Hyperalgesia and Spinal Pge2 Release' [patent_app_type] => utility [patent_app_number] => 12/064013 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12617 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0319/20080319065.pdf [firstpage_image] =>[orig_patent_app_number] => 12064013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 185649 [patent_doc_number] => 07645898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-12 [patent_title] => 'Selective androgen receptor modulators and method of use thereof' [patent_app_type] => utility [patent_app_number] => 11/505499 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 43 [patent_no_of_words] => 47071 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/645/07645898.pdf [firstpage_image] =>[orig_patent_app_number] => 11505499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5136652 [patent_doc_number] => 20070078281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Process for the Preparation of Iopamidol' [patent_app_type] => utility [patent_app_number] => 11/464981 [patent_app_country] => US [patent_app_date] => 2006-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3224 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078281.pdf [firstpage_image] =>[orig_patent_app_number] => 11464981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154871 [patent_doc_number] => 20070037754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/501926 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42758 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037754.pdf [firstpage_image] =>[orig_patent_app_number] => 11501926 [rel_patent_id] =>[rel_patent_doc_number] =>)